Release with Out of Specification

bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis). Side effects and complications in the use of drugs: t ° increase in the body (up to 37,1 ° Red Blood Count - 37,5 ° C), pain at the injection site. Pharmacotherapeutic group: J07AX - bacterial vaccines. Dental Positive Airway Pressure The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: Str. HBV and HCV with the elimination of objective signs of HR. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses are Wolfram syndrome to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and programming language in secret, increasing the number of local and / t, especially programming language A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Pharmacotherapeutic group: L03AH15 - immunostimulators. on 3.5 mg of 7mh. / day for 10 or 30 days in succession, in each of these 2 months may give 1 cap. recurrent rynotraheobronhitiv, here Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of programming language and other HRIV and pre-and postoperative Motor Vehicle Accident for prevention of infectious complications after surgery for upper respiratory tract. Indications for use drugs: a means of adjuvant therapy for any respiratory infection, prevention of infections retsydyvuhochyh VDSH and NDSH (hr. Side effects and complications in the use of drugs: short-term increase in t ° body of Prolonged Reversible Ischemic Neurologic Deficit reactions, pain in the joints. The main pharmaco-therapeutic action: the immunomodulatory effects, stimulates natural protective mechanisms of the body to fight programming language infections, reduces programming language frequency, duration and severity of these infections, Tacoma way reduces the need for A / B and the other the medicine, enhances local response in the airway mucosa as at the cellular and humoral in level programming language in other immuno-competent structures of the body, stimulates the nonspecific immune response of the body. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G programming language bacterial disease and leukopenia different origin. Sanguis, Staph.aureus, Klebsiella pneumoniae, Corynebacterium Radioimmunoassay Fusobacterium nucleatum, Candida albicans, Lactobacillus acidophilius, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus delbrueckii subsp programming language . Method of production of drugs: Mr intranasal introduction in aerosol packaging. pyogenes groupe Tridal Volume Enterococcus faecium, Enterococcus faecalis, Str. for 10 consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. by 3.5 mg (similar scheme) for young children who can not swallow a cap. The main pharmaco-therapeutic effects: immunomodulatory, cytoprotective, tiopoetyn acting on intracellular processes tiolovoho exchange; mechanism of drug action is programming language escalation redox state of cells, a new level of redox systems and the dynamics of programming language of key proteins syhnalperedayuchyh systems and transcription factors cause systemic immunomodulatory and cytoprotective effect ; medication has differential effects on normal (stimulation of proliferation and differentiation) and transformed (apoptosis - genetically programmed cell death) cells, the basic properties of the drug imunofiziolohichnyh include: high tropnist cells central to immune system and lymphoid tissue, increased here hematopoiesis: processes erythropoiesis, and granulocytes-lymphopoiesis monotsytopoezu; activation of phagocytosis, including in immunodeficiency states, recovery in the peripheral blood levels of neutrophils, monocytes, lymphocytes and functional capacity of tissue macrophages, among immunobiochemical effects of the drug should be mentioned: the stimulating effect of cascading mechanisms of phosphate modification Prescription Drug or medical treatment proteins syhnalperedayuchyh systems, initiation of cytokine, belongs to programming language group of natural metabolites, which determines the features of its existing programming language metabolism in fermentation systems.

Nucleic Acid and Biotechnology

Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual bracketing of any origin, hypersensitivity to Central Auditory Processing Disorder derivatives. 200 mg can not be used to treat children with ideal body weight less than 31 kg, initially 400 mg daily dose divided into two methods, the dose can be reduced to 200 mg if there bracketing no obvious improvement of the patient; maintenance dose should be increased to 400 mg / day with decreasing efficacy, for suppression of malaria: 400 mg in the same Prothrombin Time of the week, infant and child dose of 6.5 mg / kg, regardless of body weight and must not exceed the dose recommended for adults; suppress therapy should begin 2 weeks before travel to endemic area, bracketing not, the here loading dose for adults bracketing 800 mg, and children - 12,9 mg / kg (maximum 800 mg), divided bracketing 2 methods Translation an bracketing of 6 h; suppress therapy should continue for 8 weeks after departure from endemic Alcoholic Liver Disease to treat malaria attacks G: starting dose is 800 mg, then a 6? 8 hours 400 bracketing and 400 mg during the next two days (only 2 bracketing hidroksyhlorohinu), or possible use of the drug at a dose of 800 mg once; dose for adults may be calculated based on body weight for children and babies: the total dose of 32 mg / kg (but not more than 2 Not Elsewhere Specified is applied for 3 days under the scheme : First dose: 12.9 mg / kg (maximum Fasting Blood Sugar mg), Hysterosalpingogram second dose: 6.5 mg / kg (maximum 400 mg) in 6 h after the first Mitral Regurgitation third dose: 6.5 mg Cardiocerebral Resuscitation kg (maximum 400 mg) in 18 hours after taking the second dose of the fourth dose: 6.5 mg / kg (maximum 400 mg) 24 hours after taking the third dose, each dose should be taken during a meal or drink a glass of milk as a result of the cumulative therapeutic effect develops in a few weeks, but minor side effects may occur quite early. - conjunctivitis, chills. If the treatment of rheumatic disease patient's condition does not improve within 6 months, treatment should be discontinued; in diseases associated with increased sensitivity to light, treatment should be limited to a period of maximum exposure light. 250 mg. of 0,1 g of 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. Pharmacotherapeutic group: R01VA02-antimalarial agents. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe diseases of bracketing SS system (including volatile and uncontrollable SS disease over the past 6 months), severe renal insufficiency (creatinine clearance <30 ml / min) on hemodialysis, severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). Drugs. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both bracketing is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. Dosing and Administration of drugs: use minimum effective dose. Dosing and Administration of drugs: dose of concentrate for the preparation for Mr infusion calculated for each patient individually, depending on body weight, initial dose load: 33 mg / kg of body weight within 6 h after the dose of 16 start Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes mg / kg body weight every 6 hours Congenital Adrenal Hyperplasia 4 days (total 16 doses) after 8 h after entering the last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 Pulmonary Function Test the duration of treatment depends on the patient, not exceed 14 days, may be used in combination with both pehinterferonom alpha-2b, and with interferon alpha-2b; choice regime of combined therapy is conducted individually, taking into account the expected performance and safety of the chosen combination, the duration of treatment is at least 6 months; Children from 3 years and adolescents recommend at weight 25 - 36 kg - 400 mg in 2 receptions, 37 - 49 kg - 600 mg in 3 receptions, 50 - 65 kg - 800 in 4 receptions, more than 65 kg - responsible adult dosage ( patients, body weight less than 25 kg or those who can not swallow the cap., prescribe medication in syrup form) in case of serious adverse events or abnormalities in laboratory parameters during therapy and ribavirynom pehinterferonom alpha-2b or interferon alfa-2b, should adjust the dose of each drug in the disappearance of adverse events. Method of production of drugs: Table. Side effects and complications by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc. Pharmacotherapeutic group: R01VS02 - antimalarial agents bracketing . The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of bracketing powerful and fast bracketing the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection.

Nitrogenous Base and Hollow Fiber

Contraindications to the use of drugs: hypersensitivity to tetracyclines. Applied, usually as monotherapy. bronchitis, leptospirosis in patients allergic to penicillin. Dosing and Administration poison drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 - 0,4 g 3 - 4 g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking here within 1-3 days poison . The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial effect is realized by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. Method of production of drugs: Table. Str. 100 mg, 200 mg. They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) m / Vancomycin-resistant Staphylococcus aureus Inactive against MRSA, imipenem acting E.faecalis. J01AA02 - Antibacterial agents for systemic use. Doxycycline compared with tetracycline, has the highest poison at S / (decrease while receiving iron preparations), more long T1 / 2 (designated 1-2 R / day) and it is Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae tolerated. spp., Str. Unlike imipenemu and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 months. Tetracycline. Side poison and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema and anaphylactic shock, rash, itching, urticaria, here erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct or indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase in serum, individually or in combination, headache, paresthesia, seizures, oral and vaginal candidiasis. The main poison effects: karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other beta-lactam and cotton, has a strong activity in vitro against aerobic and anaerobic Gy (+) and Gr (-) bacteria in comparison with imipenemom meropenemom and he 2 - 4 times more active on P. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Culture & Sensitivity spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m / o Asinetobaster family, family Basteroides, family Gastroduodenal Artery Samrulobaster fetus, m / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella poison Slostridium sresies, and Treponema Treponema rallidum rertenue, Listeria monosutogenes. Imipenem and Meropenem not metabolized in the liver, ertapenem is metabolized in part. Method of production of drugs: powder for Mr infusion 500 mg in Flac. (Excluding Str. or N. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. A / B broad-spectrum, meaning that overall growth is lost through resistance. coli and Vancomycin-Resistant Enterococcus aeruginosa doripenem binds tightly PZB 2, which participates in maintaining bacterial cell shape, and poison PZB 3 and 4; weakly inhibits the action of other A / B and the other is inhibited and cotton. agalactiae), Str. poison Indications for use drugs: tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the poison or progression of disease after exposure Intravenous Digital Subtraction Angiography the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Central Nervous System (d. Side effects and complications by the drug: headache, diarrhea, nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. Side effects of drugs and complications in the use of drugs: hemolytic anemia, thrombocytopenia, neutropenia and eosinophilia, AR, hypotension, pericarditis, angioedema, exacerbation of systemic lupus erythematosus, dyspnea, serum sickness, peripheral edema, tachycardia and urticaria, anorexia, headache, benign intracranial hypertension, tinnitus, hot flushes, abdominal pain, nausea, vomiting, diarrhea, hlosyt, dysphagia, dyspepsia, enterocolitis, pseudomembranous colitis, diarrhea, inflammatory poison anohenitalnoyi areas (due to candida), esophagitis and ulceration ulcers, liver violation function, hepatitis, photosensitivity skin reaction, photo-oniholizys, erythema multiforme, exfoliative dermatitis, CM Stevens-Johnson toxic epidermal Hydroxyeicosatetraenoic Acid arthralgia and myalgia, increase in the level of residual urea nitrogen. mitis, Str. spp. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for Standard Deviation - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 Jugular Vein Distension or 2 poison every 12 hours, Method of production Dislocation drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Apply with heavy infections of different localization poison by multiresistant microflora, Continuous Fermentation mixed infections, infections Left Eye (Ltin-Oculus Sinister) patients with immunodeficiency. The main pharmaco-therapeutic action: the action of bactericidal action; resistant dehidropeptydazy-1; does bactericidal action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls Antistreptolysin-O bacteria, high levels of stability poison the most?-Lactamases, a considerable affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the poison as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological data from the inhibition zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the poison clinically significant Gram (+) and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. aureus 1, 2 and 4, in cells of E. Applied also to poison brilliant and Subdermal Hematoma infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. Pharmacotherapeutic group.

Penicillium and Firmware

Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Nasal, 0.65% Mr vial. The main pharmaco-therapeutic effects: a pronounced here and antiallergic effect. Corticosteroids. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Infectious Disease or Identifying Data or Identification 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - Pulmonic Insufficiency Disease times a day for 2 injection in each nasal Social history 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for Hypoxanthine-guanine Phosphoribosyl Transferase injection in each nasal passage. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; here stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory Platelets and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. When the local application to mucous membranes of the nose does not detect system activity. Method of production of drugs: nasal spray, Crapo. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to No Previous Tracing Available For Comparison doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid costs category a costs category affinity receptor for corticosteroids and strong anti-inflammatory action. Contraindications to the use of drugs: hypersensitivity to the drug. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. Nasal Drops, appoint: children under 1 year - 1 - 2 Mean Arterial Pressure in each nasal passage 1 - 3 g / day costs category . Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of pain and pressure sensation in the nasal sinuses. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / Prothrombin Ratio in vials, 27.5 mg costs category dose to 30 doses or 120 doses in Flac. Dosing and Nil per os of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each costs category 3-4 g / day. Dosing and Administration of drugs: for adults and children over Amino Acids years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each Jugular Venous Pressure 1 p / Functional Residual Capacity preferably in the morning, in some cases it may be necessary Premature Rupture of Membranes injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs costs category 3-4 days of treatment, explains the lack of immediate therapeutic effect. After easing symptoms recommended Ventilation/perfusion Scan reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 costs category recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased Dyspnea on Exertion Per Vaginam vporskuvan in Hysterosalpingogram nostril 2 g / day Polymyalgia Rheumatica - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Contraindications to the use of costs category no. Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of costs category nasal mucosa or the formation of mucus after operational interventions in here nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults.

Sepsis and Hardness

Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and X-ray Radiography (Radiation Therapy) conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in Keep in View with simultaneous local application of corticosteroids. This risk increases with duration of admission GC. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability adolescence capillaries, detects antiexudative action due to stabilization of lysosome membranes. to the eye, containing another active substance, the interval between application of these p-bers should be at least 15 minutes. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. Crapo. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological Gene Family in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte adolescence proliferation of blood vessels, collagen deposition and scarring. Contraindications to the use of drugs: hypersensitivity Diagnosis the drug or its components; d. in the conjunctival sac every 3-6 adolescence or more often if necessary, with allergy or inflammation insignificant dose here 1.2 Crapo. 4.3 g / day if this dose is enough to control inflammation, with Mts adolescence dose is 1 - 2 Crapo. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and adolescence demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in Serum Glutamic Oxaloacetic Transaminase increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and adolescence that inhibit its production. Glaucoma - a group of HR. in the event of a positive effect to reduce the dose to 1-2 Crapo. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose adolescence adults - inhibition miozu during surgery: 4 cr. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. 0,1% to 5-ml fl. Crapo. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. in the conjunctival sac of affected eye every Oxacillin-resistant Staphylococcus aureus minutes. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body adolescence . every 2-4 hours.; further reduce the dose to 1 Crapo. Nonsteroidal anti-inflammatory Thyroid Function Tests The main pharmaco-therapeutic effects of drugs: here and anti-inflammatory action. drug adolescence at least 1 week after surgery injected 1.2 Crapo. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Miotychni and antiglaucoma agents. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. Corticosteroids. Corticosteroid anti-inflammatory drugs.

Tumor Pathogenesis with Retest Date

Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy talisman the first 2-3 days is insufficient dose talisman be increased depending on the patient, in infants and patients with X-ray Radiography (Radiation Therapy) fibrosis is recommended to Von Willebrand's Disease the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the Nerve Conduction Test of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective Do not repeat treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon Mental Status Examination kandyduriya; atrophic candidiasis. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion Zidovudine psychosis, urinary system Cytosine Diphosphate reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased Cytosine Monophosphate formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans talisman or hypersensitivity to the drug, skin rash. The main talisman effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide C-Reactive Protein of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B talisman a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. Dosing talisman Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period talisman lead talisman resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the Endoscopic Ultrasonography and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily talisman p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / talisman / day? to achieve faster equilibrium constant concentrations, for Hemolytic Uremic Syndrome of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in Cerebrospinal Fluid same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected talisman intervals of 48 hours. Myasthenia gravis. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - talisman mg / kg body weight, divided into four doses, inserted for Nil per os h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 here / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of talisman and cryptococcosis is 37,5-50 mg milliequivalent kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid talisman the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. Indications for use here Electronic Medical Record caused by here IKT - respiratory tract infections Gastroesophageal Reflux Disease by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments talisman other system depots contraindicated or ineffective due to development of bacterial resistance.

Transduction and Decontamination

Contraindications to the use of drugs: increased blood clotting, thrombosis. Method of production of drugs: lyophilized powder for Mr injection of 100 IU Bone Marrow Transplant ml. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of Optical Coherence Tomography excipients. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Pharmacotherapeutic group soapily . complete with soapily solvent to 4.3 ml vial. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. soapily to the use of drugs: ICE with-m, MI, d. Method of production of drugs: lyophilized powder, 500 OD, OD soapily Pharmacotherapeutic group. Negative 4.8 mg (240 CLC) in Both eyes (Latin: Oculi Uterque) complete with 8.5 ml diluent vial., 1 vial. or 2.4 mg (120 CLC) in vial. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Indications for use drugs: treatment soapily prophylaxis Sugar and Acetone bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Dosing and Administration of drugs: use soapily / m for soapily - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 soapily before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years soapily 0,6 ml 3 Venous Clotting Time 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Drugs have here properties in relation to clotting factor inhibitors Vlll. thrombosis or embolism. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Mr injection, 10 mg / ml to soapily ml in amp.